Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Woolfson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature|February 26, 2020
The messy biological basis of cultureAdrian Woolfson
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2025
ABI and generative biology: A new paradigm for gene therapy, genome engineering, and engineered cell therapyAdrian Woolfson
Science (New York, N.Y.)|March 27, 2025
An end to human exceptionalism<b>The Decline and Fall of the Human Empire: Why Our Species Is on the Edge of Extinction</b> <i>Henry Gee</i> St. Martin's Press, 2025. 288 ppAdrian Woolfson
Lancet (London, England)|March 21, 2026
On the computability of biological machinesAdrian Woolfson
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2026
To make biology programmable, we must master its generative grammarAdrian Woolfson, Jef D Boeke
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
New Mouse Models to Investigate the Efficacy of Drug Combinations in Human Chronic Myeloid LeukemiaHanyang Lin, Adrian Woolfson, Xiaoyan Jiang
Pharmaceutics|March 29, 2023
The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid LeukemiaAndrew Wu, Kelly A Turner, Adrian Woolfson, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human diseasePeter Ellmark, Adrian Woolfson, Larissa Belov, et al.
Oncotarget|September 17, 2014
Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cellsHanyang Lin, Min Chen, Katharina Rothe, et al.
Pharmacogenomics|August 5, 2006
The application of CD antigen proteomics to pharmacogenomicsAdrian Woolfson, Peter Ellmark, Jeremy S Chrisp, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature|February 26, 2020
The messy biological basis of cultureAdrian Woolfson
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2025
ABI and generative biology: A new paradigm for gene therapy, genome engineering, and engineered cell therapyAdrian Woolfson
Science (New York, N.Y.)|March 27, 2025
An end to human exceptionalism<b>The Decline and Fall of the Human Empire: Why Our Species Is on the Edge of Extinction</b> <i>Henry Gee</i> St. Martin's Press, 2025. 288 ppAdrian Woolfson
Lancet (London, England)|March 21, 2026
On the computability of biological machinesAdrian Woolfson
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2026
To make biology programmable, we must master its generative grammarAdrian Woolfson, Jef D Boeke
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
New Mouse Models to Investigate the Efficacy of Drug Combinations in Human Chronic Myeloid LeukemiaHanyang Lin, Adrian Woolfson, Xiaoyan Jiang
Pharmaceutics|March 29, 2023
The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid LeukemiaAndrew Wu, Kelly A Turner, Adrian Woolfson, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human diseasePeter Ellmark, Adrian Woolfson, Larissa Belov, et al.
Oncotarget|September 17, 2014
Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cellsHanyang Lin, Min Chen, Katharina Rothe, et al.
Pharmacogenomics|August 5, 2006
The application of CD antigen proteomics to pharmacogenomicsAdrian Woolfson, Peter Ellmark, Jeremy S Chrisp, et al.
Pageof 2